Table 3.
Frequency of patients by fast-track scenario types, stratified by cancer site, age and sex.
| Number of Patients (%) for Each Scenario | |||||
|---|---|---|---|---|---|
| All Scenarios (n = 2105, 39.6% *) |
Visible Haematuria (n = 305, 5.7% *) |
Unspecified Haematuria (n = 1373, 25.8% *) |
Recurrent UTIs (n = 382, 7.2% *) |
Abdominal Mass (n = 45, 0.8% *) |
|
| Cancer Site | |||||
| Bladder | 1713 (81.4%) | 264 (86.6%) | 1129 (82.2%) | 310 (81.2%) | 10 (22.2%) |
| Kidney | 311 (14.8%) | 29 (9.5%) | 194 (14.1%) | 54 (14.1%) | 34 (75.6%) |
| UTUC | 81 (3.8%) | 12 (3.9%) | 50 (3.6%) | 18 (4.7%) | 1 (2.2%) |
| Time to diagnosis | |||||
| Days (IQR) | 55 (34–95) | 50 (30–79) | 52 (33–89) | 83 (43–151) | 60 (26–92) |
| Diagnosis beyond | |||||
| 90 days | 571 (27.1%) | 54 (17.7%) | 332 (24.2%) | 173 (45.3%) | 12 (26.7%) |
| Age groups | |||||
| <35 | 7 (0.3%) | 2 (0.7%) | 5 (0.4%) | 0 (0.0%) | 0 (0.0%) |
| 35–44 | 32 (1.5%) | 5 (1.6%) | 18 (1.3%) | 9 (2.4%) | 0 (0.0%) |
| 45–54 | 141 (6.7%) | 23 (7.5%) | 85 (6.2%) | 29 (7.6%) | 4 (8.9%) |
| 55–64 | 330 (15.7%) | 51 (16.7%) | 231 (16.8%) | 39 (10.2%) | 9 (20.0%) |
| 65–74 | 688 (32.7%) | 94 (30.8%) | 463 (33.7%) | 119 (31.2%) | 12 (26.7%) |
| 75–84 | 664 (31.5%) | 94 (30.8%) | 433 (31.5%) | 123 (32.2%) | 14 (31.1%) |
| 85+ | 243 (11.5%) | 36 (11.8%) | 138 (10.1%) | 63 (16.5%) | 6 (13.3%) |
| Sex | |||||
| Male | 1511 (71.8%) | 237 (77.7%) | 1068 (77.8%) | 181 (47.4%) | 25 (55.6%) |
| Female | 594 (28.2%) | 68 (22.3%) | 293 (21.3%) | 201 (52.6%) | 20 (44.4%) |
IQR: Interquartile range; UTIs: Urinary tract infections; UTUC: Upper tract urothelial cancer. * Percentages calculated against total cohort of 5319 patient.